Skip to main content

Table 2 Quantitative variables of the subjects as a function of the diagnosis of premorbid metabolic syndrome based on the WHO proposal

From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

  Total n = 621 Pre-MetS n = 136 Non Pre-MetS n = 485 p
Age (years) 48.5 (SD = 12.4) 54.5 (SD = 9.2) 46.8 (SD = 12.7) <0.001
Waist C (cm) 92.0 (SD = 13.6) 103.3 (SD = 11.8) 88.8 (SD = 12.3) <0.001
BMI (kg/m2) 26.3 (SD = 4.5) 29.8 (SD = 4.6) 25.3 (SD = 3.9) <0.001
Fasting glucose(mg/dl) 93.7 (SD = 14.3) 105.5 (SD = 17.9) 90.3 (SD = 10.9) <0.001
Total cholesterol (mg/dl) 205.3 (SD = 39.9) 219.5 (SD = 41.1) 201.4 (SD = 38.7) <0.001
HDL-cholesterol (mg/dl) 58.8 (SD = 14.7) 49.2 (SD = 13.4) 61.5 (SD = 14.0) <0.001
Triglyceride (mg/dl) 122.7 (SD = 83.4) 189.3 (SD = 132.7) 103.8 (SD = 48.8) <0.001
SBP (mm Hg) 126.8 (SD = 16.2) 138.3 (SD = 15.5) 123.6 (SD = 14.9) <0.001
DBP (mm Hg) 77.0 (SD = 10.4) 82.7 (SD = 10.7) 75.4 (SD = 9.6) <0.001
CVR (Score) 1.5 (SD = 1.9) 2.5 (SD = 2.3) 1.2 (SD = 1.5) <0.001
CVR (Regicor) 3.3 (SD = 2.3) 4.8 (SD = 2.6) 2.8 (SD = 1.9) <0.001
  1. p ≤ 0.05 is considered to be statistically significant.
  2. Data are expressed as means (Standard Deviation).
  3. Pre-MetS premorbid metabolic syndrome; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular risk.